Gilead 实时图表

金融票据基础知识

Weekly Search
Weekly
Daily
日期 关闭 更改 更改(%): 开盘价

Gilead news

Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

最新新闻

显示更多
Alec Malloy 2025 五月 29, 16:00

Tempus stock: TEM stock drops after short seller questions revenue sources

Stocks
Frances Wang 2025 五月 29, 16:00

Gap Lists Tariff Costs: Gap Stock Falls After Retailer Forecasts Flat Sales

Stocks
Tommy Yap 2025 五月 29, 16:00

Morning Note: Trump Tariff Swings; Tokyo Inflation Spikes; US PCE Eyed

Morning Note
Ghko B 2025 五月 28, 16:00

Tariff news update: US trade court blocks Trump “liberation day” tariffs

Stocks
Frances Wang 2025 五月 28, 16:00

Crypto market today: How high will Bitcoin get this year?

Cryptocurrencies
Frances Wang 2025 五月 28, 16:00

Joby Stock Is Climbing Today: what’s going on with Joby Aviation?

Stocks
Tommy Yap 2025 五月 28, 16:00

Morning Note: USD Jumps on Tariff Block; NVIDIA's Strong Q1; Costco Earnings Due

Morning Note Forex Tech
Frances Wang 2025 五月 27, 16:00

GOOGL Share Price Analysis: Why Alphabet Stock Is Up Today?

Stocks

信息

点差

0.72

点差(%)

0.6565 %

杠杆

1:10

隔夜利息(买入)

-0.0597 %

隔夜利息(卖出)

-0.0292 %

币种

USD

交易时间

市场关闭

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析和统计

开盘价

---

昨收

---

52 周高点/低点

--- – ---

市值

138213146624

在外流通股份

1243929984

财报日(下一)

2013-01-28

股息收益率

2025-06-27

除息日

2025-06-13

远期年度股息率

3.16

远期年股息率

0.0284

每股收益

4.71

详细了解此金融票据

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

相关金融票据

资产
出售
买入
更改(%):
相关金融票据

latest_education_articles

显示更多
Trustpilot